Report Detail
Global Antibody Drug Conjugate (ADC) Drug Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4062622 |
- 25 June, 2020 |
- Global |
- 125 Pages |
- QYResearch |
- Medical Industry
Global Antibody Drug Conjugate (ADC) Drug Scope and Market Size
Antibody Drug Conjugate (ADC) Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibody Drug Conjugate (ADC) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
by Technology
Mmunomedics Technology
Immunogen Technology
Seattle Genetics Technology
Others
by Product Type
Kadcyla
Adcertis
Market segment by Application, split into
Biotechnology Companies
Specialized Cancer Centers
Biopharmaceutical Companies
Academic Research Institutes
Hospitals
Others
Based on regional and country-level analysis, the Antibody Drug Conjugate (ADC) Drug market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Antibody Drug Conjugate (ADC) Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Oxford Bio Therapeutics
Synthon
Progenics Pharmaceuticals
Bayer HealthCare
Millennium Pharmaceuticals
Pfizer
Concortis Bio therapeutics
Roche Holding AG
Seattle Genetics
Heidelberg Pharma
Mersana Therapeutics
Astellas Pharma/Agensys
AbbVie Inc
Celldex Therapeutics
Immunomedics
Agensys
Genentech
ImmunoGen
Sanofi
Genmab
Amgen
Novartis
Eli Lilly
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Mmunomedics Technology
- 1.2.3 Immunogen Technology
- 1.2.4 Seattle Genetics Technology
- 1.2.5 Others
- 1.3 Market by Application
- 1.3.1 Global Antibody Drug Conjugate (ADC) Drug Market Share by Application: 2020 VS 2026
- 1.3.2 Biotechnology Companies
- 1.3.3 Specialized Cancer Centers
- 1.3.4 Biopharmaceutical Companies
- 1.3.5 Academic Research Institutes
- 1.3.6 Hospitals
- 1.3.7 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Antibody Drug Conjugate (ADC) Drug Market Perspective (2015-2026)
- 2.2 Global Antibody Drug Conjugate (ADC) Drug Growth Trends by Regions
- 2.2.1 Antibody Drug Conjugate (ADC) Drug Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Antibody Drug Conjugate (ADC) Drug Historic Market Share by Regions (2015-2020)
- 2.2.3 Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Antibody Drug Conjugate (ADC) Drug Players by Market Size
- 3.1.1 Global Top Antibody Drug Conjugate (ADC) Drug Players by Revenue (2015-2020)
- 3.1.2 Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Players (2015-2020)
- 3.2 Global Antibody Drug Conjugate (ADC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Antibody Drug Conjugate (ADC) Drug Revenue
- 3.4 Global Antibody Drug Conjugate (ADC) Drug Market Concentration Ratio
- 3.4.1 Global Antibody Drug Conjugate (ADC) Drug Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugate (ADC) Drug Revenue in 2019
- 3.5 Key Players Antibody Drug Conjugate (ADC) Drug Area Served
- 3.6 Key Players Antibody Drug Conjugate (ADC) Drug Product Solution and Service
- 3.7 Date of Enter into Antibody Drug Conjugate (ADC) Drug Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Drug Conjugate (ADC) Drug Breakdown Data by Type (2015-2026)
- 4.1 Global Antibody Drug Conjugate (ADC) Drug Historic Market Size by Type (2015-2020)
- 4.2 Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Type (2021-2026)
5 Antibody Drug Conjugate (ADC) Drug Breakdown Data by Application (2015-2026)
- 5.1 Global Antibody Drug Conjugate (ADC) Drug Historic Market Size by Application (2015-2020)
- 5.2 Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Antibody Drug Conjugate (ADC) Drug Market Size (2015-2026)
- 6.2 North America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020)
- 6.3 North America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020)
- 6.4 North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Antibody Drug Conjugate (ADC) Drug Market Size (2015-2026)
- 7.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020)
- 7.3 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020)
- 7.4 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Antibody Drug Conjugate (ADC) Drug Market Size (2015-2026)
- 8.2 China Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020)
- 8.3 China Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020)
- 8.4 China Antibody Drug Conjugate (ADC) Drug Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Antibody Drug Conjugate (ADC) Drug Market Size (2015-2026)
- 9.2 Japan Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020)
- 9.3 Japan Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020)
- 9.4 Japan Antibody Drug Conjugate (ADC) Drug Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size (2015-2026)
- 10.2 Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020)
- 10.3 Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020)
- 10.4 Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
- 11.1 Oxford Bio Therapeutics
- 11.1.1 Oxford Bio Therapeutics Company Details
- 11.1.2 Oxford Bio Therapeutics Business Overview
- 11.1.3 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
- 11.1.4 Oxford Bio Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020))
- 11.1.5 Oxford Bio Therapeutics Recent Development
- 11.2 Synthon
- 11.2.1 Synthon Company Details
- 11.2.2 Synthon Business Overview
- 11.2.3 Synthon Antibody Drug Conjugate (ADC) Drug Introduction
- 11.2.4 Synthon Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 11.2.5 Synthon Recent Development
- 11.3 Progenics Pharmaceuticals
- 11.3.1 Progenics Pharmaceuticals Company Details
- 11.3.2 Progenics Pharmaceuticals Business Overview
- 11.3.3 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Introduction
- 11.3.4 Progenics Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 11.3.5 Progenics Pharmaceuticals Recent Development
- 11.4 Bayer HealthCare
- 11.4.1 Bayer HealthCare Company Details
- 11.4.2 Bayer HealthCare Business Overview
- 11.4.3 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Introduction
- 11.4.4 Bayer HealthCare Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 11.4.5 Bayer HealthCare Recent Development
- 11.5 Millennium Pharmaceuticals
- 11.5.1 Millennium Pharmaceuticals Company Details
- 11.5.2 Millennium Pharmaceuticals Business Overview
- 11.5.3 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Introduction
- 11.5.4 Millennium Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 11.5.5 Millennium Pharmaceuticals Recent Development
- 11.6 Pfizer
- 11.6.1 Pfizer Company Details
- 11.6.2 Pfizer Business Overview
- 11.6.3 Pfizer Antibody Drug Conjugate (ADC) Drug Introduction
- 11.6.4 Pfizer Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 11.6.5 Pfizer Recent Development
- 11.7 Concortis Bio therapeutics
- 11.7.1 Concortis Bio therapeutics Company Details
- 11.7.2 Concortis Bio therapeutics Business Overview
- 11.7.3 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
- 11.7.4 Concortis Bio therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 11.7.5 Concortis Bio therapeutics Recent Development
- 11.8 Roche Holding AG
- 11.8.1 Roche Holding AG Company Details
- 11.8.2 Roche Holding AG Business Overview
- 11.8.3 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Introduction
- 11.8.4 Roche Holding AG Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 11.8.5 Roche Holding AG Recent Development
- 11.9 Seattle Genetics
- 11.9.1 Seattle Genetics Company Details
- 11.9.2 Seattle Genetics Business Overview
- 11.9.3 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Introduction
- 11.9.4 Seattle Genetics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 11.9.5 Seattle Genetics Recent Development
- 11.10 Heidelberg Pharma
- 11.10.1 Heidelberg Pharma Company Details
- 11.10.2 Heidelberg Pharma Business Overview
- 11.10.3 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Introduction
- 11.10.4 Heidelberg Pharma Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 11.10.5 Heidelberg Pharma Recent Development
- 11.11 Mersana Therapeutics
- 10.11.1 Mersana Therapeutics Company Details
- 10.11.2 Mersana Therapeutics Business Overview
- 10.11.3 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
- 10.11.4 Mersana Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 10.11.5 Mersana Therapeutics Recent Development
- 11.12 Astellas Pharma/Agensys
- 10.12.1 Astellas Pharma/Agensys Company Details
- 10.12.2 Astellas Pharma/Agensys Business Overview
- 10.12.3 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Introduction
- 10.12.4 Astellas Pharma/Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 10.12.5 Astellas Pharma/Agensys Recent Development
- 11.13 AbbVie Inc
- 10.13.1 AbbVie Inc Company Details
- 10.13.2 AbbVie Inc Business Overview
- 10.13.3 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Introduction
- 10.13.4 AbbVie Inc Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 10.13.5 AbbVie Inc Recent Development
- 11.14 Celldex Therapeutics
- 10.14.1 Celldex Therapeutics Company Details
- 10.14.2 Celldex Therapeutics Business Overview
- 10.14.3 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
- 10.14.4 Celldex Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 10.14.5 Celldex Therapeutics Recent Development
- 11.15 Immunomedics
- 10.15.1 Immunomedics Company Details
- 10.15.2 Immunomedics Business Overview
- 10.15.3 Immunomedics Antibody Drug Conjugate (ADC) Drug Introduction
- 10.15.4 Immunomedics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 10.15.5 Immunomedics Recent Development
- 11.16 Agensys
- 10.16.1 Agensys Company Details
- 10.16.2 Agensys Business Overview
- 10.16.3 Agensys Antibody Drug Conjugate (ADC) Drug Introduction
- 10.16.4 Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 10.16.5 Agensys Recent Development
- 11.17 Genentech
- 10.17.1 Genentech Company Details
- 10.17.2 Genentech Business Overview
- 10.17.3 Genentech Antibody Drug Conjugate (ADC) Drug Introduction
- 10.17.4 Genentech Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 10.17.5 Genentech Recent Development
- 11.18 ImmunoGen
- 10.18.1 ImmunoGen Company Details
- 10.18.2 ImmunoGen Business Overview
- 10.18.3 ImmunoGen Antibody Drug Conjugate (ADC) Drug Introduction
- 10.18.4 ImmunoGen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 10.18.5 ImmunoGen Recent Development
- 11.19 Sanofi
- 10.19.1 Sanofi Company Details
- 10.19.2 Sanofi Business Overview
- 10.19.3 Sanofi Antibody Drug Conjugate (ADC) Drug Introduction
- 10.19.4 Sanofi Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 10.19.5 Sanofi Recent Development
- 11.20 Genmab
- 10.20.1 Genmab Company Details
- 10.20.2 Genmab Business Overview
- 10.20.3 Genmab Antibody Drug Conjugate (ADC) Drug Introduction
- 10.20.4 Genmab Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 10.20.5 Genmab Recent Development
- 11.21 Amgen
- 10.21.1 Amgen Company Details
- 10.21.2 Amgen Business Overview
- 10.21.3 Amgen Antibody Drug Conjugate (ADC) Drug Introduction
- 10.21.4 Amgen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 10.21.5 Amgen Recent Development
- 11.22 Novartis
- 10.22.1 Novartis Company Details
- 10.22.2 Novartis Business Overview
- 10.22.3 Novartis Antibody Drug Conjugate (ADC) Drug Introduction
- 10.22.4 Novartis Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 10.22.5 Novartis Recent Development
- 11.23 Eli Lilly
- 10.23.1 Eli Lilly Company Details
- 10.23.2 Eli Lilly Business Overview
- 10.23.3 Eli Lilly Antibody Drug Conjugate (ADC) Drug Introduction
- 10.23.4 Eli Lilly Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
- 10.23.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on Antibody Drug Conjugate (ADC) Drug. Industry analysis & Market Report on Antibody Drug Conjugate (ADC) Drug is a syndicated market report, published as Global Antibody Drug Conjugate (ADC) Drug Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Antibody Drug Conjugate (ADC) Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
